针对骨髓瘤中的信号通路:机制和临床研究
Ziyu Ji1, Jianlin Shen2, Yujian Lan1
1School of Integrated Traditional Chinese and Western Medicine Southwest Medical University Luzhou Sichuan China.
MedComm
|July 13, 2023
概括
骨髓瘤 (OS) 研究确定了关键信号通路作为潜在的生物标志物和治疗点. 了解这些途径为诊断和治疗这种普遍存在的骨癌提供了新的途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 骨髓瘤 (OS) 是一种常见的青少年骨癌,肺转移和耐药性构成重大临床挑战.
- 目前的治疗方法,如新辅助化疗和手术,可以改善结果,但强调需要新的治疗策略.
- 识别新的生物标志物对于开发针对OS的向疗法至关重要.
研究的目的:
- 审查最近关于骨髓瘤中信号通路的调节作用的发现.
- 探索这些途径作为潜在的生物标记物和OS的治疗点.
- 讨论当前和新兴的OS治疗方法,包括基于途径的疗法和传统中医药.
主要方法:
- 关于骨髓瘤分子生物学和信号通路的最新科学文献的综述.
- 基因组学进步及其对生物标记物识别的贡献的分析.
- 对OS的当代分子分类的检查.
- 通过信号通路调查传统中医在OS治疗中的作用.
主要成果:
- 基因组分析已经确定了OS诊断,预后和向治疗的显著分子生物标志物.
- 关键的信号通路 (Wnt/β-catenin,PI3K/AKT/mTOR,JAK/STAT3,Hippo,Notch,PD-1/PD-L1,MAPK,NF-κB) 是OS发病,进展,转移和治疗反应的组成部分.
- 基于途径的疗法和传统中医药在通过调节基因和蛋白质表达来抑制OS细胞生长方面表现有前途.
结论:
- 信号通路代表了有前途的生物标记物和骨髓瘤的治疗点.
- 整合基因组,分子和临床数据可以增强OS诊断和治疗策略.
- 对基于途径的疗法和传统医学的进一步研究有可能改善OS管理.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Canonical Wnt Signaling Pathway
8.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K


